Submitted by Anonymous (not verified) on 9 July 2026 - 16:15
Human medicines European public assessment report (EPAR): Zavesca, miglustat, Date of authorisation: 20/11/2002, Date of refusal: 16/06/2009, Revision: 36, Status: Authorised
Source: